AUSTIN, Texas–(BUSINESS WIRE)–Ollin Biosciences, Inc. (Ollin), a clinical-stage biotech advancing best-in-disease therapies for vision-threatening diseases, today announced positive topline results from its randomized, head-to-head Phase 1b JADE clin…
Author: Business Wire
GenSight Biologics Reports Cash Position as of December 31, 2025, and Provides Business Updates
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (“GenSight Biologics” or the “Company”) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for ret…
GenSight Biologics publie sa situation de trésorerie au 31 décembre 2025 et fait un point sur son activité
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (« GenSight Biologics » ou la « Société ») (Euronext : SIGHT, ISIN : FR0013183985, éligible PEA-PME), une société biopharmaceutique spécialisée dans le développement et la commercialisation de…
Ashvattha Therapeutics Appoints Life Healthcare Veteran George Montgomery as Executive Chairman to Lead Corporate Development and Strategic Partnerships
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Ashvattha Therapeutics (“Ashvattha”), a clinical-stage company developing a nanomedicine therapeutic that traverses the blood-retinal barrier in areas of inflammation selectively targeting and reprogramming activa…
Ray Therapeutics Appoints Scott Braunstein, M.D., as Chairman of the Board of Directors
BERKELEY, Calif.–(BUSINESS WIRE)–Ray Therapeutics Appoints Scott Braunstein, M.D., as Chairman of the Board of Directors
SpliceBio Initiates Dose-Expansion Portion of Phase 1/2 ASTRA Clinical Trial for SB-007, a Dual-AAV Gene Therapy for Stargardt Disease
BARCELONA–(BUSINESS WIRE)–SpliceBio, a clinical-stage genetic medicines company pioneering protein splicing to address diseases caused by mutations in large genes, today announced that the first patient has been dosed in the Part B dose-expansion por…
Abbelight Announces Successful Series B Investment led by AVANT BIO to Accelerate Imaging Innovation and Scale Adoption Across a Broader Customer Base
PARIS–(BUSINESS WIRE)–Abbelight, a global leader and a pioneer in super-resolution microscopy end-to-end solutions, today announced a successful Series B financing round led by AVANT BIO, a growth equity firm focused on enabling technologies shaping …
FairJourney Bio to present at J.P. Morgan 2026 Healthcare Conference
PORTO, Portugal–(BUSINESS WIRE)–FairJourney Bio (FJBio), a global leader in antibody discovery and development, announced today that its Chief Executive Officer, Dr. Werner Lanthaler, will present at the J.P. Morgan 2026 Healthcare Conference, taking…
Allotex Advances from European Commercialization to U.S. Clinical Phase
BOSTON–(BUSINESS WIRE)– #eye–Allotex Inc., a commercial-stage ophthalmic company with active European market adoption, today announced that the U.S. Food and Drug Administration (FDA) has conditionally approved its Investigational Device Exemption (…
Allotex Advances from European Commercialization to U.S. Clinical Phase
BOSTON–(BUSINESS WIRE)– #eye–Allotex Inc., a commercial-stage ophthalmic company with active European market adoption, today announced that the U.S. Food and Drug Administration (FDA) has conditionally approved its Investigational Device Exemption (…
Pandorum Technologies und Nucelion Therapeutics geben strategische Zusammenarbeit in APAC-Märkten bekannt, um exosom-basierte Therapie zur Geweberegeneration bei Augenerkrankungen zu entwickeln
BANGALORE, Indien und HYDERABAD, Indien–(BUSINESS WIRE)–Pandorum Technologies, ein Unternehmen für regenerative Medizin im klinischen Stadium, das eine Plattform der nächsten Generation für programmierbare Geweberegeneration aufbaut, gab heute eine s…
Samenvatting: Pandorum Technologies en Nucelion Therapeutics kondigen strategische samenwerking aan voor productie van op exosomen gebaseerde weefselregeneratieve therapie voor oogziekten in APAC-markten
BANGALORE, India & HYDERABAD, India–(BUSINESS WIRE)–Pandorum Technologies, een bedrijf in de klinische fase van regeneratieve geneeskunde dat een platform van de volgende generatie ontwikkelt voor programmeerbare weefselregeneratie, heeft vandaag een…
Pandorum Technologies et Nucelion Therapeutics annoncent une collaboration stratégique pour la fabrication d’un traitement régénératif tissulaire à base d’exosomes pour les maladies oculaires sur les marchés de la région Asie-Pacifique
BANGALORE, Inde et HYDERABAD, Inde–(BUSINESS WIRE)–Pandorum Technologies, une société de médecine régénérative au stade clinique qui développe une plateforme de nouvelle génération pour la régénération tissulaire programmable, a annoncé aujourd’hui u…
Riassunto: Pandorum Technologies e Nucelion Therapeutics annunciano una collaborazione strategica imperniata sulla produzione di una terapia rigenerativa dei tessuti basata su esosomi mirata alle patologie oculari nei mercati APAC
BANGALORE, India, e HYDERABAD, India–(BUSINESS WIRE)–Pandorum Technologies, specialista della medicina rigenerativa in fase clinica impegnato nello sviluppo di una piattaforma di nuova generazione per la rigenerazione programmabile dei tessuti, oggi …
Resumen: Pandorum Technologies y Nucelion Therapeutics anuncian una colaboración estratégica para elaborar una terapia regenerativa de tejidos con base en exosomas para enfermedades oculares en mercados de APAC
BANGALORE (India) e HYDERABAD (India)–(BUSINESS WIRE)–Pandorum Technologies, una empresa de medicina regenerativa de fase clínica que está diseñando una plataforma de próxima generación para regeneración de tejidos programable, anunció hoy una colabo…
Alcon Terminates Agreement to Acquire STAAR Surgical
GENEVA–(BUSINESS WIRE)–Alcon Terminates Agreement to Acquire STAAR Surgical
National Vision Announces Participation in the 2026 ICR Conference
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today announced that the Company is scheduled to present at the 2026 ICR Conference on Tuesday, January 13, 2026, at 9:00 a.m. Eastern Time….
SpliceBio nombra a Don Muñoz director financiero
BARCELONA–(BUSINESS WIRE)–SpliceBio, una empresa de medicamentos genéticos en fase clínica pionera en el empalme de proteínas para tratar enfermedades causadas por mutaciones en genes grandes, ha anunciado hoy el nombramiento de Don Muñoz como direct…
STAAR Surgical Announces Preliminary Results of Special Meeting of Stockholders
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, announced that based on preliminary estimates …
Lions World Vision Institute Advances Accessible Care with Vision Health Center Groundbreaking in Ybor City
TAMPA, Fla.–(BUSINESS WIRE)–Lions World Vision Institute (LWVI) broke ground on its new $16 million Vision Health Center in Tampa’s historic Ybor City.